Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer

Wei Ni(Tianjin Medical University Cancer Institute and Hospital), Ran Tian(Tianjin Medical University Cancer Institute and Hospital), Ruifang Niu(Tianjin Medical University Cancer Institute and Hospital), Zhaosong Wang(Tianjin Medical University Cancer Institute and Hospital), Hui Liu(Tianjin Medical University Cancer Institute and Hospital), Fei Zhang(Tianjin Medical University Cancer Institute and Hospital), Li Liu(Shanghai Ocean University), He Zhang(Tianjin Medical University Cancer Institute and Hospital), Yanfen Cui(Tianjin Medical University Cancer Institute and Hospital), Mingzhu Zhang(Nanjing Normal University), Wei Du, Hui Guo(Hebei Medical University), Yueni Mo(Tianjin Medical University Cancer Institute and Hospital), Zhiyong Wang(Tianjin Medical University Cancer Institute and Hospital)
Drug Delivery and Translational Research
August 22, 2024
10.1007/s13346-024-01690-y
Cited by 7

Related Papers

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Functions of Shp2 in cancer
|Journal of Cellular and Molecular Medicine|2015|250
<scp>TGF</scp>‐β transactivates <scp>EGFR</scp> and facilitates breast cancer migration and invasion through canonical Smad3 and <scp>ERK</scp>/Sp1 signaling pathways
|Molecular Oncology|2017|179
Gram‐Negative Periodontal Bacteria Induce the Activation of Toll‐Like Receptors 2 and 4, and Cytokine Production in Human Periodontal Ligament Cells
|Journal of Periodontology|2010|141